camptothecin has been researched along with swainsonine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Abdelhay, ES; Bastos, LG; de-Freitas-Junior, JC; Freire-Neto, CA; Morgado-Díaz, JA; Rocher, BD | 1 |
2 other study(ies) available for camptothecin and swainsonine
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
N-glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells.
Topics: Blotting, Western; Caco-2 Cells; Camptothecin; Cell Movement; Cell Survival; Cisplatin; Colorectal Neoplasms; Flow Cytometry; HCT116 Cells; HT29 Cells; Humans; Irinotecan; Polysaccharides; Swainsonine; Tunicamycin | 2012 |